Additionally, the overexpression of VAPB or PTPIP51 has been found to enhance ER–mitochondria signaling and promote synaptic signal transmission, suggesting the potential of targeting MAMs for therapeutic interventions in neurodegenerative diseases like ALS/FTD.46 This evidence concerns the gene VAPB and frontotemporal dementia.